Gemifloxacin as first line treatment for community acquired pneumonia in mexico- A cost—effectiveness study
May 1, 2013, 00:00
10.1016/j.jval.2013.03.414
https://www.valueinhealthjournal.com/article/S1098-3015(13)00485-3/fulltext
Title :
Gemifloxacin as first line treatment for community acquired pneumonia in mexico- A cost—effectiveness study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00485-3&doi=10.1016/j.jval.2013.03.414
First page :
A89
Section Title :
Infection
Open access? :
No
Section Order :
1455